NurExone Biologic Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 20, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 30, 2022	Dec '21 Dec 30, 2021
Market Capitalization	50	14	17	-
Market Cap Growth	267.92%	-14.84%	-	-
Enterprise Value	46	13	12	-
Last Close Price	0.70	0.29	0.39	-
PB Ratio	12.48	57.03	5.89	-
P/TBV Ratio	10.16	57.03	5.89	-
Debt / Equity Ratio	0.01	6.34	0.01	0.89
Quick Ratio	6.40	0.33	4.17	1.67
Current Ratio	6.49	1.04	4.46	1.74
Return on Equity (ROE)	-232.06%	-318.51%	-499.17%	-
Return on Assets (ROA)	-105.50%	-92.09%	-123.02%	-
Return on Capital (ROIC)	-143.94%	-130.46%	-159.74%	-
Earnings Yield	-14.23%	-33.76%	-66.15%	-
FCF Yield	-14.98%	-28.40%	-31.58%	-
Buyback Yield / Dilution	-37.86%	-18.52%	-129.36%	-
Total Shareholder Return	-37.86%	-18.52%	-129.36%	-

Source: S&P Capital IQ. Standard template. Financial Sources.